Life BioScience (LBSI) has launched a new MicroFab Division that provides a broad range of micro-fabrication services for medical devices made in APEX Glass, APEX Ceramic, Silicon, Pyrex, SOI, Kapton and other standard materials used in the semiconductor manufacturing process.

The new division services are targeted at customers seeking convenient and cost efficient solutions for their micro-fabrication needs whether they are in the early or final stage of product development and whether a full or single range of capabilities is required.

Life MicroFab capabilities include most processes needed to fabricate a CMOS integrated circuit, from process development to device fabrication. Single process capabilities, such as photolithography, thin films deposition, wet and dry etching or metrology services are also available.

Life MicroFab offers prototyping through its high volume production of microfluidic, biochip and other glass devices utilizing the patent-pending photo-structurable APEX Glass and APEX Ceramic, which are proprietary and exclusive products licensed from Life BioScience.

The company said that the glass is photo-sensitive and can be fabricated into 3D glass or ceramic devices in a high volume batch process. The photo-definable glass improves yields, decreases process times and enables more complex micro-system part fabrication without the need for expensive process equipment.

Blake Ridgeway, president and CEO of LBSI, the parent company of Life MicroFab, said: “Researchers and product development groups often lack the in-house capabilities needed for early design feasibility, prototyping, and process development. Life MicroFab gives them a leg up with a one-stop solution for all of their micro-fabrication needs whether they are working on government contracts or commercial product launches.

“R&D and advances in innovation need no longer be limited by lab size or constrained by in-house capabilities. Life MicroFab’s strong knowledge base provides an invaluable foundation for exploring design feasibility and speeding up process development.”